2009 BIO International Convention
Click here to go to the previous page
The Unique Role of In-House Pharma/Biotech Lawyers: Legal and Ethical Risks
Track
:
Legal Issues
Program Code:
3482
Date:
Thursday, May 21, 2009
Time:
8:00 AM to 9:30 AM
EST
Location:
B303
SPEAKER
(S):
Kevin Dinan, Partner, King & Spalding, LLP
Tim Stow, US General Counsel, UCB, Inc
Bobby Woo, Partner, King & Spalding, LLP
Description
This session will cover the unique risks faced by in-house counsel at pharmaceutical and biotechnology companies, including individual liability for FDA violations and application of privilege with respect to FDA regulatory interactions. It will cover other selected risk areas from both a legal and ethical perspective.
• Review the current legal and ethical landscape emerging from recent cases and events
• Sensitize in-house counsel to legal and ethical responsibilities
• Offer strategies to mitigate legal and ethical risks